Amgen

Will FDA advisers shoot down Amgen's cancer vaccine?
Fierce Biotech
Thu, 02/12/15 - 02:15 pm
FDA
Amgen
vaccines
T-Vec
melanoma
Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono
Fierce Biotech
Tue, 02/10/15 - 10:40 am
R&D
Merck
Novo Nordisk
Amgen
Sanofi
Ono Pharmaceutical
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Amgen, Inc. Files Petition To Stop Novartis (NVS) From Launching Neupogen Bilosimilar
Bidness Etc.
Tue, 02/10/15 - 08:38 am
Amgen
Novartis
Neupogen
biosimilars
Moody's: Patent-cliff challenges will continue to dog big pharma
BioPharma Dive
Wed, 02/4/15 - 01:43 pm
patents
patent cliff
Big Pharma
Pfizer
Eli Lilly
Merck
Amgen
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars
Seeking Alpha
Wed, 02/4/15 - 01:18 pm
Regeneron
Sanofi
Amgen
drug pricing
How the Actavis deal upended Allergan No. 2's CEO ambitions
Yahoo/Reuters
Wed, 02/4/15 - 09:58 am
Allergan
Amgen
M&A
Doug Ingram
Amgen: Study shows its biosimilar version of popular arthritis drug Humira about as effective
Yahoo/AP
Wed, 02/4/15 - 08:25 am
Amgen
biosimilar
Humira
rheumatoid arthritis
Novartis AG Anticipates Price War With Amgen, Eli Lilly & Co. Over Psoriasis Drugs
Bidness Etc.
Wed, 01/28/15 - 11:31 am
Novartis
Amgen
Eli Lilly
drug pricing
psoriasis
Amgen profit beats forecasts
Marketwatch
Tue, 01/27/15 - 05:16 pm
Amgen
earnings
What to Expect When Amgen (AMGN) Reports Fourth-Quarter Earnings After Market Close Today
TheStreet.com
Tue, 01/27/15 - 04:29 pm
Amgen
earnings
5 Big Biotech Earnings Releases To Watch This Week
Yahoo/Benzinga
Mon, 01/26/15 - 06:49 pm
biotech
earnings
Amgen
Biogen Idec
Vertex Pharmaceuticals
Celgene
Alexion
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
cancer
CAR-T
Amgen
Celgene
Bluebird Bio
Novartis
Kite Pharma
Pfizer
Cellectis
Juno Therapeutics
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Sanofi
Regeneron
Amgen
alirocumab
evolocumab
PCSK9 inhibitors
Novartis psoriasis drug approval could upend market
Medical Marketing and Media
Thu, 01/22/15 - 09:55 am
Novartis
psoriasis
Cosentyx
Amgen
Stelara
Enbrel
Drug companies find common ground over Colorado's 'biosimilars' legislation
Bizjournals.com
Wed, 01/21/15 - 09:42 am
Colorado
biologics
generics
Amgen
Sandoz
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix
Bidness Etc.
Sat, 01/17/15 - 04:01 pm
Amgen
Vectibix
metastatic colorectal cancer
mCRC
Kite Pharma/Amgen: A Strong Combination
Seeking Alpha
Thu, 01/15/15 - 05:50 pm
Kite Pharma
Amgen
Juno Therapeutics
Bellicum
Ziopharm
CAR-T
After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
Bloomberg
Wed, 01/14/15 - 10:08 am
hepatitis C
Express Scripts
Regeneron
Amgen
PCSK9 inhibitor

Pages